2021
DOI: 10.1080/1028415x.2021.1927604
|View full text |Cite
|
Sign up to set email alerts
|

The effect of ketogenic diet escalation in adolescents and adults with drug-resistant epilepsy: a prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(12 citation statements)
references
References 35 publications
0
12
0
Order By: Relevance
“…Other studies did not find a significant difference in the efficacy of the ketogenic diet in groups with differing ketogenic ratios [13]. Increasing the ratio of the diet was associated with less compliance in adolescents and adults, though the latter reported an improvement in general health score questionnaires [14].…”
Section: Classic Ketogenic Dietmentioning
confidence: 80%
“…Other studies did not find a significant difference in the efficacy of the ketogenic diet in groups with differing ketogenic ratios [13]. Increasing the ratio of the diet was associated with less compliance in adolescents and adults, though the latter reported an improvement in general health score questionnaires [14].…”
Section: Classic Ketogenic Dietmentioning
confidence: 80%
“…Most studies in this review focused on diet interventions (n = 16) for PWE. 17,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39] Diet interventions included ketogenic diet (n = 6), 17,27,29,33,37,38 modified Atkins diet (n = 9), 25,26,28,30,32,33,35,36,39 low glutamate diet (n = 1), 34 and low glycemic index therapy (n = 3). 26,31,37 Additional lifestyle interventions included physical activity (n = 9) [40][41][42][43][44][45][46] and sleep (n = 1).…”
Section: Overview Of Interventionsmentioning
confidence: 99%
“…The primary outcome of interest was results pertaining to adult nervous system function. Of the sixty-four publications reporting neurological outcomes (Table 2), twenty-two provided measures on cortical excitability (nineteen epilepsy studies (21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39) , one narcolepsy (40) , one glucose transporter-1 deficiency syndrome (41) and one general physiology (42) ). Additional categories included fifteen psychological publications (eleven mood and/or cognition (43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55) , one schizophrenia (56) and one orexinergic system (57) ), twelve neurodegenerative disease publications (three Alzheimer's disease (58)(59)(60) , three multiple sclerosis (61)(62)(63) , three cognitive impairment (64)(65)…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%
“…Weight loss prepost intervention was common (n = 45), but not always significant. Five studies reported no weight loss (26,32,36,38,48) , and nine did not report weight changes (25,45,53,56,63,64,67,70,83) .…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%